100 filings
8-K
EPZM
Epizyme, Inc.
12 Aug 22
Termination of a Material Definitive Agreement
12:00pm
8-K
EPZM
Epizyme, Inc.
9 Aug 22
Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update
7:12am
8-K
EPZM
Epizyme, Inc.
27 Jun 22
Ipsen to acquire Epizyme, expanding its portfolio in oncology
6:14am
8-K
EPZM
Epizyme, Inc.
24 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:38pm
8-K
EPZM
Epizyme, Inc.
19 May 22
Departure of Directors or Certain Officers
7:57am
8-K
ojj6t1jasqgng
10 May 22
Epizyme Reports First Quarter 2022 Financial Results and Provides Business Update
7:09am
8-K
nw6lj7 96ayl87
6 Apr 22
Departure of Directors or Certain Officers
5:00pm
8-K
9nx6ylo
15 Mar 22
Epizyme Announces Executive Appointment and Provides Tazemetostat Clinical Update
7:09am
8-K
9c90nkcvc8 sr5
1 Mar 22
Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
7:39am
8-K
gmzbg4ce
27 Jan 22
Entry into a Material Definitive Agreement
5:08pm
8-K
azkvs5s
10 Jan 22
Epizyme Provides Business Highlights, Preliminary Fourth Quarter and Full
7:05am
8-K
nzwby
22 Dec 21
Termination of a Material Definitive Agreement
4:05pm
8-K
3m6963561c1vir1
18 Nov 21
Epizyme Announces Updates to Its Board of Directors
6:42am
8-K
5erje2v rp
9 Nov 21
Epizyme Reports Third Quarter 2021 Financial Results and Provides Business Update
6:39am
8-K
yed8rzh
29 Oct 21
Departure of Directors or Certain Officers
6:49am
8-K
eji5wee g9u1bi3apv
16 Aug 21
Entry into a Material Definitive Agreement
4:57pm
8-K
sdhv6l
9 Aug 21
Epizyme Reports Second Quarter 2021 Financial Results and Provides Business Update
7:41am
8-K
uzy ny1wt
28 Jun 21
Departure of Directors or Certain Officers
5:20pm
8-K
yskjs4yvets6
16 Jun 21
Submission of Matters to a Vote of Security Holders
6:55am
8-K
jculwkye
6 May 21
Epizyme Provides Business Update and Reports First Quarter 2021 Financial Results
6:56am